Fluconazole Drugs
Market: Introduction
·
Fluconazole is an antifungal medication that belongs to a class of drugs
called azole antifungals, which are used for various yeast and fungal
infections such as oropharyngeal candidiasis, vaginal candidiasis, esophageal
candidiasis, fungal meningitis and other candida infections including urinary
tract infection and peritonitis. Fluconazole products are available in tablet,
powder, or suspension and solution form.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=80475
·
In the U.S., the use of fluconazole, a new antifungal agent, was
introduced in 1990
Key Drivers and
Opportunities of Global Fluconazole Drugs Market
·
Increase in incidence of fungal infection is anticipated to boost the
global fluconazole drugs market. For instance, according to Centers for Disease
Control and Prevention, in 2017, there were over 75,000 hospitalizations and
nearly 9 million outpatient visits for fungal diseases in the U.S.
·
Staying in the hospital for an injury or an illness with weak immune
system leads to increased risk for causing hospital acquired infection. Rise in
prevalence of nosocomial infections is anticipated to fuel the global market.
According to a study published in Annals of Burns and Fire Diseases, conducted
during 2011 to 2014, the incidence of nosocomial fungal infection was 10%.
Request COVID Analysis on Fluconazole Drugs Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=80475
·
Fungal diseases pose an important threat to public health for several
reasons, thus key players are focusing on research and development to expand
the clinical application of fluconazole is contribute to drive the growth of
market. Moreover, strategic investment by key players is likely augment the
market. For instance, in July 2020, ANI Pharmaceuticals, Inc. acquired
Fluconazole Tablets USP, 50mg, 100mg, 150mg, and 200mg from a private company.
This acquisition enabled ANI Pharmaceutical to strengthen its product portfolio
and enhance the margin opportunity and competitive position of this product.
·
Providing education to healthcare providers and raising awareness among
the public about the threat of fungal diseases is fueling the demand for
fluconazole and subsequently, driving the market
·
Rise in prevalence and awareness about fungal infection and government
initiatives in developing countries offer lucrative opportunities in the global
market. For instance, According to the Second Australian Atlas of Healthcare
Variation, an estimated 73,777 hospitalizations for kidney and urinary tract
infections were reported in Australia in 2014–2015.
Request Customization on Fluconazole Drugs Market Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=80475
North America to
Capture Major Share of Global Fluconazole Drugs Market
·
North America is expected to account for major share of the global
fluconazole drugs market as the region is a hub for key market players and
a rise in the demand for fluconazole owing to a surge in the prevalence of
nosocomial infections.
·
The fluconazole drugs market in Asia Pacific is projected to expand at a
rapid pace during the forecast period owing to a rise in awareness about fungal
diseases
Key Players
Operating in Global Fluconazole Drugs Market
The global fluconazole drugs market
is highly concentrated due to the presence of key players. A large number of
manufacturers hold a major share in their respective regions. Demand for
fluconazole products has increased in emerging as well as developed markets.
Thus, industry players are adopting practices of appointing third-party
distributors to expand market presence. This has led to a surge in the number
of distributors and suppliers in emerging markets.
Pre Book Fluconazole Drugs Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=80475<ype=S
Major players operating in the global
fluconazole drugs market are:
·
Pfizer Inc.
·
Glenmark Pharmaceutical Inc
·
Cipla Inc
·
Sun Pharmaceutical Industries Ltd.
·
Mylan Pharmaceuticals
·
Novartis AG (Sandoz)
·
Teva Pharmaceuticals
·
Citron Pharma
·
VELLINTON HEALTHCARE
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides forward-looking
insight for thousands of decision makers. We have an experienced team of
analysts, researchers, and consultants who use proprietary data sources and
various tools and techniques to gather and analyze information. Our business
offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector — such as
pharmaceuticals, chemical, energy, food & beverages, semiconductors,
med-devices, consumer goods and technology. These reports provide in-depth
analysis and deep segmentation to possible micro levels. With wider scope and
stratified research methodology, our syndicated reports thrive to provide
clients to serve their overall research requirement.
Contact
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com
